September 2025 | Global Perspectives
Using AI to Identify Pathologic Myopia and Myopic Maculopathy
How research on the use of AI can translate to future clinical applications.
Yining Wang, MD; Tien Yin Wong, MBBS, MMED (Ophth), MPH, PhD; and Kyoko Ohno-Matsui, MD, PhD
September 2025 | Features
Teaching Fibrovascular Membrane Dissection
Use this structured approach to teach fellows how to manage complex diabetic eye disease in the OR.
James Rice, FCOphth(SA), MPH; Thabang Morris, FCOphth(SA); and Jonel Steffen, FCOphth(SA)
September 2025 | Medical Retina
Immunosuppressive Therapy for Severe Noninfectious Choroiditis
These cases illustrate the value of not hesitating to begin aggressive treatment.
Carl P. Herbort, Jr, MD, PD, and Ioannis Papasavvas, MD
September 2025 | Features
Modern Diabetes Care: What You Need to Know
The changing landscape of systemic diabetes care is affecting ocular complications such as diabetic retinopathy.
Samaantar Joshi, BS; Khiem Sy Nguyen, BS; Jonathan B. Lin, MD, PhD; and Ehsan Rahimy, MD
September 2025 | Meeting Minutes
SEVR: A Tradition of Insight and Innovation
The Southeastern Vitreoretinal Conference continued its legacy of collegial learning with case discussions and lively lectures.
Riley J. Lyons, MD, and Ollya V. Fromal, MD
September 2025 | Meeting Minutes
Top Panel Discussions at ARDS 2025
Experts share medical and surgical tips and explore the effects of shifting practice patterns.
Jonathan N. Levenson, MD
September 2025 | Features
Minding the Gap: Diabetes Day Reduces Barriers to Care
Growing statewide effort increases access to diabetic eye care and reduces preventable blindness through free screening services.
Christian D. Raimondo, MS; Leah Prischak, BS; Charlotte N. Shields, MD; Rachel E. Cain; Elizabeth Goldstein, BS; Madison Woods, BS; Ari H. August, BA; Arslon Humayun, BA; and Allen C. Ho, MD
September 2025 | Ocular Oncology
Reducing Chemotherapy Duration for High-Risk Retinoblastoma
Three cycles may offer comparable clinical benefit to six cycles while reducing treatment burden.
Madison M. Woods, BA; Robert J. Medina, BA; and Carol L. Shields, MD
September 2025 | Medical Editors' Page
A Call for Holistic Care
Allen C. Ho, MD, and Robert L. Avery, MD
September 2025 | Fellows' Focus
Pneumatics: A Fellow’s Perspective
Keep these tips and tricks in mind as you master pneumatic retinopexy.
Flavius Beca, MD
September 2025 | Imaging
Pearls for Imaging the Peripheral Retina
A brief review of ultra-widefield OCT.
Szilárd Kiss, MD, FASRS, and Peyman Razavi, MD
September 2025 | Surgical Pearls
The Pressure Is On: A Case of Ocular Ischemia
Beware of acute central retinal artery hypoperfusion during pars plana vitrectomy.
J. Daniel Diaz, MD, and Ninel Z. Gregori, MD
September 2025 | Features
GLP-1 Receptor Agonists and the Eye
Researchers are working to understand the effects of these popular new therapies on ocular structures.
Suraj Bala, BS; Julia H. Joo, MD; and Aleksandra V. Rachitskaya, MD, FASRS
September 2025 | Features
The Emerging Role of AI in DR Screening
AI-powered technologies could help ophthalmologists meet the growing needs of this patient population.
Jorge C. P. Rocha, MD, PhD, and Majda Hadziahmetovic, MD
September 2025 | Features
Utility of Fluorescein Angiography in DME
If you want to assess vessel leakage and peripheral pathology in diabetic eye disease, FA is still your best bet.
Jason Keil, MD, PhD; Caitlyn Cooper, MA; and Yannis M. Paulus, MD
September 2025 | Features
Managing DR in Patients with Good Vision
The DRCR Retina Network sheds light on the optimal treatment approaches.
Gage Hazelton, BA, and Deepak Sambhara, MD